With an increasing focus on biomarkers in dementia research, illustrating the role of
neuropsychological assessment in detecting mild cognitive impairment (MCI) and …

Alzheimer's disease (AD) and frontotemporal dementia (FTD) are the most common
neurodegenerative earlyonset dementias. Despite the fact that both conditions have a very …

Introduction Harmonized neuropsychological assessment for neurocognitive disorders, an
international priority for valid and reliable diagnostic procedures, has been achieved only in …

Background: The asymptomatic at-risk phase might be the optimal time-window to establish
clinically meaningful endpoints in Alzheimer's disease (AD). Objective: We investigated …

Although Alzheimer's disease criteria promote the use of biomarkers, their maturity in clinical
routine still needs to be assessed. In the light of the oncology framework, we conducted a …

Hearing loss is an important risk factor for dementia. However, the mechanisms that relate
these disorders are still unknown. As a proxy of this relationship, we studied the structural …

Background: Neuropsychiatric symptoms and cognitive impairment are independent
contributors of functional impairment in activities of daily living (ADL) in Alzheimer's disease …

Background With the global population aging and life expectancy increasing, dementia has
turned a priority in the health care system. In Chile, dementia is one of the most important …

Frontotemporal dementia (FTD) is the third most common form of dementia across all age
groups and is a leading cause of early-onset dementia. The Frontotemporal dementia (FTD) …

The present study aimed at validating the Memory Associative Test of the district of Seine-
Saint-Denis (TMA)-93, a new test of episodic memory. The TMA-93 was proposed to mostly …